RAP 0.00% 20.5¢ resapp health limited

Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-44

  1. 1,427 Posts.
    lightbulb Created with Sketch. 1268
    think you are missing the point. With the current suite of medical tests, doctors cannot agree on a diagnosis. ResAPP are trying to compare their diagnosis with a moving target. Something the doctors cant even agree on. Maybe the app diagnosis is always right but its not comparing against truth. its comparing against the doctors opinion....and they cant agree.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.